James C. Blair

This profile gathers the share dealings of James C. Blair across 25 companies, led by Orexigen Therapeutics, Inc., Clovis Oncology, Inc. and Volcano Corp. The record holds 259 filings, for trades running from 6 February 2006 to 20 August 2019.

In open-market terms, that means 78 purchases worth €105.3M on one side and 32 sales worth €48.7M on the other. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 6 share grants. 2019 to date brings 2 purchases and 1 sale.

Half of the purchases are above €148k and half below.

Most recently, on 20 August 2019, the filings show an open-market purchase worth €103k in Clovis Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.